TVGN: Total Utang marang Modal Tevogen Bio

Logo perusahaan publik Tevogen Bio (TVGN)

The price history on the debt-to-equity chart for Tevogen Bio Holdings (TVGN) is 0.00. This biotech startup focuses on personalized T-cell therapy, assuming significant investment risks. The business relies on developing immune mechanisms to combat oncology and viruses. Personnel stability is supported by large-scale scientific research that attracts the industry's leading immunologists.

TVGN - Total Utang marang Modal Tevogen Bio ing rentang 21.02.2024 - 31.10.2026

Rincian metrik lan analitis perusahaan Tevogen Bio Inc. (TVGN)

- rega lan prakiraan konsensus rega:
Bagan rega Tevogen Bio|TVGN - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Kapitalisasi pasar Tevogen Bio|TVGN - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Akuntansi saben Saham Tevogen Bio|TVGN - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku tevogen.com|TVGN - Nilai Agregat Aset
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Tevogen Bio Holdings|TVGN - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Tevogen Bio Holdings|TVGN - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Tevogen Bio|TVGN - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Tevogen Bio|Likuiditas cepet tevogen.com
- statistik bathi lan rasio pasar:
TVGN - Penghasilan resik perusahaan
Pambiji fundamental:Tevogen Bio, TVGN
Barang utama tevogen.com

Tevogen Bio Holdings is facing an acute liquidity shortage due to costly clinical trials in the absence of revenue. This indicator measures the proportion of debt obligations within the equity structure, determining the financial leverage. An increase in this metric signals a critical rise in the credit load. It is essential for investors to monitor the sustainability of liabilities to eliminate the risk of bankruptcy. Analyzing the debt-to-equity ratio allows for an assessment of the business model's viability.

Pesaing Tevogen Bio Holdings

Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|VKTX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Utang marang Ekuitas|Utang marang Modal Denali Corp (DNLI)|Rasio Total Utang marang Ekuitas HRMY|BHVN (biohavenpharma.com) - Utang Agregat marang Modal|Total Utang marang Modal AMLX|TRVI - Utang marang Modal|Praxis Medicines - Rasio Total Utang marang Ekuitas|Anavex Life Sciences Corp - Utang marang Ekuitas|CBLL - Utang marang Ekuitas|Utang marang Modal Prothena Corporation PLC|ALEC: Total Utang marang Modal|Rasio Utang marang Modal Annexon Biosciences ANNX|OMER (Omeros Corp) - Total Utang marang Modal|Utang marang Modal Neurogene Therapeutics NGNE|Utang marang Ekuitas AC Immune (ACIU)|voyagertherapeutics.com - Rasio Utang marang Ekuitas|Neumora Therapeutics, Inc. - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SCLX|Alpha Cognition Corp - Total Utang marang Modal|CGTX: Utang marang Ekuitas|IKT: Total Utang marang Modal|SAVA - Koefisien Total Utang marang Modal|Utang marang Ekuitas Assertio Holdings|Utang marang Modal Coya COYA|Rasio Total Utang marang Ekuitas VTGN (Vistagen Therapeutics)|OVID (ovidrx.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ABOS (Acumen Pharmaceuticals)|Rasio Kabeh Utang marang Dana Pribadi CRVO|ATHE - Utang marang Ekuitas|Utang marang Modal Clene Inc.|pepgen.com (PEPG) - Utang marang Ekuitas|JUNS (Jupiter Neurosciences, Inc.) - Utang marang Ekuitas|RLMD (Relmada Therapeutics) - Total Utang marang Modal|Rasio Utang marang Ekuitas ANVS (annovisbio.com)|Total Utang marang Modal GRCE|Koefisien Total Utang marang Modal Firefly Neuroscience, Inc.|Utang marang Ekuitas Klotho Neurosciences KLTO|NRSN: Rasio Utang marang Ekuitas|Reviva Pharmaceuticals - Total Utang marang Modal|Rasio Utang marang Modal MetaVia Inc (MTVA)|NeurAxis (NRXS) - Utang marang Ekuitas|HSDT - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas PASG|NEUP (Neuphoria) - Utang Agregat marang Modal|Rasio Total Utang marang Ekuitas NERV (Minerva Neurosciences)|Utang marang Ekuitas ATHA (athira.com)|Total Utang marang Modal ADXN (Addex Therapeutics Ltd)|Rasio Utang marang Modal Alzamend Neuro Inc.|CYCN - Utang marang Ekuitas|PTIX (Protagenic Therapeutics) - Rasio Utang marang Ekuitas|pasitheaclinics.com (KTTA) - Utang marang Ekuitas|Rasio Utang marang Ekuitas CRGT|ATXI (Avenue Therapeutics, Inc.) - Total Utang marang Modal|Utang marang Modal Brainstorm Cell Therapeutics Inc. BCLI|Rasio Total Utang marang Ekuitas CARA (Cara Therapeutics, Inc)|Total Utang marang Modal Chromocell (CHRO)|Utang marang Ekuitas Eliem Therapeutics Inc. ELYM|Rasio Kabeh Utang marang Dana Pribadi ITCI|LBPH - Utang marang Ekuitas|Utang marang Modal Marinus Pharmaceuticals Inc|NKGN (NKGen) - Rasio Total Utang marang Ekuitas|NRBO: Utang Agregat marang Modal|SAGE (Sage Therapeutics, Inc.) - Total Utang marang Modal|Utang marang Modal synaptogen.com SNPX|Rasio Total Utang marang Ekuitas TRVN (Trevena)|Utang marang Ekuitas VIGL (vigilneuro.com)|Utang marang Ekuitas Anew Medical WENA|Cerevel Corp (CERE) - Utang marang Modal